Oncology Medical News about everely Anemic Children; Iron; Folic Acid; Multivitamins; Anthelminthics

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Treatment Response to Iron and Folic Acid Alone Is the Same as with Multivitamins and/or Anthelminthics in Severely Anemic 6- to 24-Month-Old Children
The Journal of Nutrition, 06/18/09

Bhutta Z et al. - Adherence to treatment was 70% for iron+folic acid, 80% for multivitamins, and almost 100% for mebendazole. Children receiving iron+folic acid alone had a response rate of 38.7% at 90 d. The additional treatment with mebendazole or multivitamins did not significantly improve cure rates or change the Hb concentration over and above iron+folic acid treatment alone. Adherence to iron+folic acid of higher than the median resulted in a better treatment response rate of 50%. High-dose daily iron+folic acid performed as well as iron+folic acid with anthelminthics and multivitamins in the treatment of severe anemia in this setting. Higher adherence may be important in enhancing treatment impact.

<< Previous
The Ste20-like kinase SLK is required for ErbB2-driven breast...

Next >>
Infrequent Detection of Germline Allele-Specific Expression of...